Results 241 to 250 of about 40,241 (253)
Some of the next articles are maybe not open access.
Expert Opinion on Biological Therapy, 2012
Until now most insulin used in developed countries is manufactured and distributed by a small number of multinational companies. Other pharmaceutical companies - many of these are located in countries such as India or China - are also able to manufacture insulin with modern biotechnological methods.
openaire +2 more sources
Until now most insulin used in developed countries is manufactured and distributed by a small number of multinational companies. Other pharmaceutical companies - many of these are located in countries such as India or China - are also able to manufacture insulin with modern biotechnological methods.
openaire +2 more sources
An Institutional Guide for Formulary Decisions of Biosimilars
Hospital Pharmacy, 2022Biologics have changed the landscape for the management of many debilitating chronic diseases but account for a significant expenditure of medications globally.
Sherine Ismail +5 more
semanticscholar +1 more source
2017
Biosimilars are a new class of drugs, which are derived from live organism through the recombinant DNA technology. These are recently introduced in the pharmaceutical field for the preparation of drug to prevent or control the diseases. Patients with diabetes and renal failure may already be receiving biosimilar epoetin and may receive same insulin in ...
Anil K. Sharma +2 more
openaire +2 more sources
Biosimilars are a new class of drugs, which are derived from live organism through the recombinant DNA technology. These are recently introduced in the pharmaceutical field for the preparation of drug to prevent or control the diseases. Patients with diabetes and renal failure may already be receiving biosimilar epoetin and may receive same insulin in ...
Anil K. Sharma +2 more
openaire +2 more sources
Patients’ Perceptions of Biosimilars: A Systematic Review
BioDrugs, 2023Qiyou Wu +4 more
semanticscholar +1 more source
Biosimilar anti-VEGF—Yardsticks to ensure biosimilarity
Eye, 2022Ashish Sharma +4 more
openaire +3 more sources
Biosimilars in IBD: What Every Clinician Needs to Know
Current Gastroenterology ReportsAnthony Angyal, Shubha Bhat
semanticscholar +1 more source
International Journal of Pharmaceutical Medicine, 2007
Schellekens, H. +2 more
openaire +3 more sources
Schellekens, H. +2 more
openaire +3 more sources